{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:22:29Z","timestamp":1771064549922,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To elucidate the molecular processes associated with the development of myopic macular degeneration (MMD), we measured the intraocular concentrations of molecular factors in emmetropic and myopic eyes. This is a retrospective clinic-based case-control study that included eyes undergoing routine cataract surgery whereby aqueous humour samples were obtained. We measured the concentrations of pigment epithelium derived factor(PEDF), matrix metalloproteinase 2(MMP-2), tissue inhibitor of metalloproteinase(TIMP-2), vascular endothelial growth factor isoform A(VEGF-A), interleukin 8(IL-8), interleukin 6(IL-6), C-reactive protein(CRP), angiopoietin 2(Ang2), and amphiregulin. 38 eyes (axial length (AL): 22.4\u201332.4\u2009mm), including 12 highly myopic (HM) eyes (AL\u2009\u2265\u200926.5\u2009mm) without MMD and 12 HM eyes with MMD but without neovascularization were included. Eyes with MMD were found to have significantly lower VEGF-A levels (p\u2009=\u20090.007) and higher MMP-2 levels (p\u2009=\u20090.02) than control eyes after adjusting for age and gender. MMP-2 levels correlated positively (r\u2009=\u20090.58, p\u2009=\u20090.002), while VEGF-A levels correlated negatively with longer axial length (r\u2009=\u2009\u22120.75, p\u2009&lt;\u20090.001). Both the concentrations of VEGF-A (<jats:italic>P<\/jats:italic>\u2009=\u20090.25) and MMP-2 (<jats:italic>P<\/jats:italic>\u2009=\u20090.69) were not significantly associated with MMD after adjusting for AL. These findings suggest that the predominant mechanism underlying the development of non-neovascular MMD may be axial elongation, driven in part by MMP-2 related mechanisms.<\/jats:p>","DOI":"10.1038\/s41598-019-52156-y","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T11:08:43Z","timestamp":1572520123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Correlation of axial length and myopic macular degeneration to levels of molecular factors in the aqueous"],"prefix":"10.1038","volume":"9","author":[{"given":"Chee Wai","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Yanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew Shih Hsiang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waseem Ahamed","family":"Shihabuddeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu Yen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2972-5227","authenticated-orcid":false,"given":"Jost B.","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3358-3516","authenticated-orcid":false,"given":"Chui Ming Gemmy","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"52156_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajo.2013.08.010","volume":"157","author":"TY Wong","year":"2014","unstructured":"Wong, T. Y., Ferreira, A., Hughes, R., Carter, G. & Mitchell, P. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. American journal of ophthalmology 157, 9\u201325 e12, https:\/\/doi.org\/10.1016\/j.ajo.2013.08.010 (2014).","journal-title":"American journal of ophthalmology"},{"key":"52156_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.12.001","volume":"52","author":"K Ohno-Matsui","year":"2016","unstructured":"Ohno-Matsui, K., Lai, T. Y., Lai, C.-C. & Cheung, C. M. G. Updates of pathologic myopia. Progress in retinal and eye research 52, 156\u2013187 (2016).","journal-title":"Progress in retinal and eye research"},{"key":"52156_CR3","first-page":"2265","volume":"18","author":"YJ Shin","year":"2012","unstructured":"Shin, Y. J., Nam, W. H., Park, S. E., Kim, J. H. & Kim, H. K. Aqueous humor concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in high myopic patients. Mol Vis 18, 2265\u20132270 (2012).","journal-title":"Mol Vis"},{"key":"52156_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ajo.2005.05.037","volume":"140","author":"N Ogata","year":"2005","unstructured":"Ogata, N. et al. Low levels of pigment epithelium-derived factor in highly myopic eyes with chorioretinal atrophy. American journal of ophthalmology 140, 937\u2013939, https:\/\/doi.org\/10.1016\/j.ajo.2005.05.037 (2005).","journal-title":"American journal of ophthalmology"},{"key":"52156_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2016.08.017","volume":"152","author":"NI Minkevich","year":"2016","unstructured":"Minkevich, N. I. et al. Abnormal pigment epithelium-derived factor processing in progressive myopia. Experimental eye research 152, 1\u20139, https:\/\/doi.org\/10.1016\/j.exer.2016.08.017 (2016).","journal-title":"Experimental eye research"},{"key":"52156_CR6","doi-asserted-by":"publisher","first-page":"5126560","DOI":"10.1155\/2016\/5126560","volume":"2016","author":"M Li","year":"2016","unstructured":"Li, M. et al. Expression of Wnt\/beta-Catenin Signaling Pathway and Its Regulatory Role in Type I Collagen with TGF-beta1 in Scleral Fibroblasts from an Experimentally Induced Myopia Guinea Pig Model. J Ophthalmol 2016, 5126560, https:\/\/doi.org\/10.1155\/2016\/5126560 (2016).","journal-title":"J Ophthalmol"},{"key":"52156_CR7","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s00417-014-2768-2","volume":"252","author":"H Zhuang","year":"2014","unstructured":"Zhuang, H. et al. Changes of TGF-beta2, MMP-2, and TIMP-2 levels in the vitreous of patients with high myopia. Graefe\u2019s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 252, 1763\u20131767, https:\/\/doi.org\/10.1007\/s00417-014-2768-2 (2014).","journal-title":"Graefe\u2019s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"},{"key":"52156_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10384-011-0027-1","volume":"55","author":"O Sawada","year":"2011","unstructured":"Sawada, O. et al. Negative correlation between aqueous vascular endothelial growth factor levels and axial length. Jpn J Ophthalmol 55, 401\u2013404, https:\/\/doi.org\/10.1007\/s10384-011-0027-1 (2011).","journal-title":"Jpn J Ophthalmol"},{"key":"52156_CR9","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1097\/IAE.0000000000001464","volume":"37","author":"JB Jonas","year":"2017","unstructured":"Jonas, J. B., Ohno-Matsui, K., Jiang, W. J. & Panda-Jonas, S. Bruch Membrane and the Mechanism of Myopization: A New Theory. Retina 37, 1428\u20131440, https:\/\/doi.org\/10.1097\/IAE.0000000000001464 (2017).","journal-title":"Retina"},{"key":"52156_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ebiom.2017.02.021","volume":"17","author":"WJ Jiang","year":"2017","unstructured":"Jiang, W. J. et al. Amphiregulin Antibody and Reduction of Axial Elongation in Experimental Myopia. EBioMedicine 17, 134\u2013144, https:\/\/doi.org\/10.1016\/j.ebiom.2017.02.021 (2017).","journal-title":"EBioMedicine"},{"key":"52156_CR11","first-page":"270","volume":"6","author":"CP Herbort","year":"2011","unstructured":"Herbort, C. P., Papadia, M. & Neri, P. Myopia and inflammation. J Ophthalmic Vis Res 6, 270\u2013283 (2011).","journal-title":"J Ophthalmic Vis Res"},{"key":"52156_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ebiom.2016.07.021","volume":"10","author":"HJ Lin","year":"2016","unstructured":"Lin, H. J. et al. Role of Chronic Inflammation in Myopia Progression: Clinical Evidence and Experimental Validation. EBioMedicine 10, 269\u2013281, https:\/\/doi.org\/10.1016\/j.ebiom.2016.07.021 (2016).","journal-title":"EBioMedicine"},{"key":"52156_CR13","doi-asserted-by":"publisher","first-page":"731461","DOI":"10.1155\/2015\/731461","volume":"2015","author":"W Chen","year":"2015","unstructured":"Chen, W. et al. Aqueous Levels of Pigment Epithelium-Derived Factor and Macular Choroidal Thickness in High Myopia. J Ophthalmol 2015, 731461, https:\/\/doi.org\/10.1155\/2015\/731461 (2015).","journal-title":"J Ophthalmol"},{"key":"52156_CR14","doi-asserted-by":"publisher","first-page":"18751","DOI":"10.1073\/pnas.0905010106","volume":"106","author":"M Saint-Geniez","year":"2009","unstructured":"Saint-Geniez, M., Kurihara, T., Sekiyama, E., Maldonado, A. E. & D\u2019Amore, P. A. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci USA 106, 18751\u201318756, https:\/\/doi.org\/10.1073\/pnas.0905010106 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"52156_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1350-9462(02)00063-0","volume":"22","author":"NA McBrien","year":"2003","unstructured":"McBrien, N. A. & Gentle, A. Role of the sclera in the development and pathological complications of myopia. Prog Retin Eye Res 22, 307\u2013338 (2003).","journal-title":"Prog Retin Eye Res"},{"key":"52156_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1080\/02713683.2016.1223317","volume":"42","author":"Y Jia","year":"2017","unstructured":"Jia, Y., Hu, D. N., Sun, J. & Zhou, J. Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients. Curr Eye Res 42, 600\u2013603, https:\/\/doi.org\/10.1080\/02713683.2016.1223317 (2017).","journal-title":"Curr Eye Res"},{"key":"52156_CR17","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1167\/iovs.14-13983","volume":"55","author":"Y Jia","year":"2014","unstructured":"Jia, Y. et al. MMP-2, MMP-3, TIMP-1, TIMP-2, and TIMP-3 protein levels in human aqueous humor: relationship with axial length. Investigative ophthalmology & visual science 55, 3922\u20133928, https:\/\/doi.org\/10.1167\/iovs.14-13983 (2014).","journal-title":"Investigative ophthalmology & visual science"},{"key":"52156_CR18","doi-asserted-by":"publisher","first-page":"e0117777","DOI":"10.1371\/journal.pone.0117777","volume":"10","author":"D Zhu","year":"2015","unstructured":"Zhu, D. et al. Intracameral interleukin 1beta, 6, 8, 10, 12p, tumor necrosis factor alpha and vascular endothelial growth factor and axial length in patients with cataract. PLoS One 10, e0117777, https:\/\/doi.org\/10.1371\/journal.pone.0117777 (2015).","journal-title":"PLoS One"},{"key":"52156_CR19","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajo.2015.01.022","volume":"159","author":"K Ohno-Matsui","year":"2015","unstructured":"Ohno-Matsui, K. et al. International photographic classification and grading system for myopic maculopathy. American journal of ophthalmology 159, 877\u2013883 e877, https:\/\/doi.org\/10.1016\/j.ajo.2015.01.022 (2015).","journal-title":"American journal of ophthalmology"},{"key":"52156_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1167\/iovs.16-20742","volume":"58","author":"CW Wong","year":"2017","unstructured":"Wong, C. W., Phua, V., Lee, S. Y., Wong, T. Y. & Cheung, C. M. Is Choroidal or Scleral Thickness Related to Myopic Macular Degeneration? Investigative ophthalmology & visual science 58, 907\u2013913, https:\/\/doi.org\/10.1167\/iovs.16-20742 (2017).","journal-title":"Investigative ophthalmology & visual science"},{"key":"52156_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3109\/02713683.2014.973043","volume":"40","author":"W Chen","year":"2015","unstructured":"Chen, W. et al. Correlation of macular choroidal thickness with concentrations of aqueous vascular endothelial growth factor in high myopia. Curr Eye Res 40, 307\u2013313, https:\/\/doi.org\/10.3109\/02713683.2014.973043 (2015).","journal-title":"Curr Eye Res"},{"key":"52156_CR22","first-page":"1","volume":"309","author":"A Sorsby","year":"1969","unstructured":"Sorsby, A. & Leary, G. A. A longitudinal study of refraction and its components during growth. Spec Rep Ser Med Res Counc (G B) 309, 1\u201341 (1969).","journal-title":"Spec Rep Ser Med Res Counc (G B)"},{"key":"52156_CR23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1755-3768.1971.tb05939.x","volume":"49","author":"JS Larsen","year":"1971","unstructured":"Larsen, J. S. The sagittal growth of the eye. IV. Ultrasonic measurement of the axial length of the eye from birth to puberty. Acta Ophthalmol (Copenh) 49, 873\u2013886 (1971).","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"52156_CR24","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ajo.2010.05.009","volume":"150","author":"N Saka","year":"2010","unstructured":"Saka, N. et al. Long-term changes in axial length in adult eyes with pathologic myopia. American journal of ophthalmology 150, 562\u2013568 e561, https:\/\/doi.org\/10.1016\/j.ajo.2010.05.009 (2010).","journal-title":"American journal of ophthalmology"},{"key":"52156_CR25","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1167\/iovs.09-4259","volume":"51","author":"AA Hussain","year":"2010","unstructured":"Hussain, A. A., Lee, Y. & Marshall, J. High molecular-weight gelatinase species of human Bruch\u2019s membrane: compositional analyses and age-related changes. Investigative ophthalmology & visual science 51, 2363\u20132371, https:\/\/doi.org\/10.1167\/iovs.09-4259 (2010).","journal-title":"Investigative ophthalmology & visual science"},{"key":"52156_CR26","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1167\/iovs.05-1590","volume":"47","author":"S Aisenbrey","year":"2006","unstructured":"Aisenbrey, S. et al. Retinal pigment epithelial cells synthesize laminins, including laminin 5, and adhere to them through alpha3- and alpha6-containing integrins. Investigative ophthalmology & visual science 47, 5537\u20135544, https:\/\/doi.org\/10.1167\/iovs.05-1590 (2006).","journal-title":"Investigative ophthalmology & visual science"},{"key":"52156_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2009.08.003","volume":"29","author":"JC Booij","year":"2010","unstructured":"Booij, J. C., Baas, D. C., Beisekeeva, J., Gorgels, T. G. & Bergen, A. A. The dynamic nature of Bruch\u2019s membrane. Prog Retin Eye Res 29, 1\u201318, https:\/\/doi.org\/10.1016\/j.preteyeres.2009.08.003 (2010).","journal-title":"Prog Retin Eye Res"},{"key":"52156_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000431129","volume":"55","author":"RG Rubio","year":"2016","unstructured":"Rubio, R. G. & Adamis, A. P. Ocular Angiogenesis: Vascular Endothelial Growth Factor and Other Factors. Dev Ophthalmol 55, 28\u201337, https:\/\/doi.org\/10.1159\/000431129 (2016).","journal-title":"Dev Ophthalmol"},{"key":"52156_CR29","doi-asserted-by":"publisher","first-page":"257381","DOI":"10.1155\/2013\/257381","volume":"2013","author":"T Wakabayashi","year":"2013","unstructured":"Wakabayashi, T., Ikuno, Y., Oshima, Y., Hamasaki, T. & Nishida, K. Aqueous Concentrations of Vascular Endothelial Growth Factor in Eyes with High Myopia with and without Choroidal Neovascularization. J Ophthalmol 2013, 257381, https:\/\/doi.org\/10.1155\/2013\/257381 (2013).","journal-title":"J Ophthalmol"},{"key":"52156_CR30","doi-asserted-by":"publisher","first-page":"2234 e2231","DOI":"10.1016\/j.ophtha.2009.12.006","volume":"117","author":"JB Jonas","year":"2010","unstructured":"Jonas, J. B., Tao, Y., Neumaier, M. & Findeisen, P. VEGF and refractive error. Ophthalmology 117, 2234 e2231, https:\/\/doi.org\/10.1016\/j.ophtha.2009.12.006 (2010).","journal-title":"Ophthalmology"},{"key":"52156_CR31","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/BF02153409","volume":"225","author":"R Guthoff","year":"1987","unstructured":"Guthoff, R., Berger, R. W. & Draeger, J. Ultrasonographic measurement of the posterior coats of the eye and their relation to axial length. Graefe\u2019s archive for clinical and experimental ophthalmology\u2009=\u2009Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 225, 374\u2013376 (1987).","journal-title":"Graefe\u2019s archive for clinical and experimental ophthalmology\u2009=\u2009Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"},{"key":"52156_CR32","doi-asserted-by":"publisher","first-page":"7578","DOI":"10.1167\/iovs.13-12772","volume":"54","author":"SA Read","year":"2013","unstructured":"Read, S. A., Collins, M. J., Vincent, S. J. & Alonso-Caneiro, D. Choroidal thickness in myopic and nonmyopic children assessed with enhanced depth imaging optical coherence tomography. Investigative ophthalmology & visual science 54, 7578\u20137586, https:\/\/doi.org\/10.1167\/iovs.13-12772 (2013).","journal-title":"Investigative ophthalmology & visual science"},{"key":"52156_CR33","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1167\/iovs.17-22144","volume":"59","author":"N Padron-Perez","year":"2018","unstructured":"Padron-Perez, N. et al. Changes in Choroidal Thickness After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy. Investigative ophthalmology & visual science 59, 1119\u20131124, https:\/\/doi.org\/10.1167\/iovs.17-22144 (2018).","journal-title":"Investigative ophthalmology & visual science"},{"key":"52156_CR34","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1097\/IAE.0000000000000122","volume":"34","author":"XS Cao","year":"2014","unstructured":"Cao, X. S., Peng, X. Y., You, Q. S., Zhang, Y. P. & Jonas, J. B. Subfoveal choroidal thickness change after intravitreal ranibizumab for idiopathic choroidal neovascularization. Retina 34, 1554\u20131559, https:\/\/doi.org\/10.1097\/IAE.0000000000000122 (2014).","journal-title":"Retina"},{"key":"52156_CR35","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1136\/bjophthalmol-2013-304555","volume":"98","author":"T Hikichi","year":"2014","unstructured":"Hikichi, T. et al. Relation between changes in foveal choroidal thickness and 1-year results of ranibizumab therapy for polypoidal choroidal vasculopathy. Br J Ophthalmol 98, 1201\u20131204, https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304555 (2014).","journal-title":"Br J Ophthalmol"},{"key":"52156_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ajo.2015.12.024","volume":"164","author":"DS Ting","year":"2016","unstructured":"Ting, D. S. et al. Choroidal Thickness Changes in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-Month Prospective Study. American journal of ophthalmology 164, 128\u2013136 e121, https:\/\/doi.org\/10.1016\/j.ajo.2015.12.024 (2016).","journal-title":"American journal of ophthalmology"},{"key":"52156_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archopht.1967.00980020061012","volume":"77","author":"IS Jain","year":"1967","unstructured":"Jain, I. S., Luthra, C. L. & Das, T. Diabetic retinopathy and its relation to errors of refraction. Arch Ophthalmol 77, 59\u201360 (1967).","journal-title":"Arch Ophthalmol"},{"key":"52156_CR38","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1167\/iovs.03-0120","volume":"44","author":"MK Ikram","year":"2003","unstructured":"Ikram, M. K., van Leeuwen, R., Vingerling, J. R., Hofman, A. & de Jong, P. T. Relationship between refraction and prevalent as well as incident age-related maculopathy: the Rotterdam Study. Investigative ophthalmology & visual science 44, 3778\u20133782 (2003).","journal-title":"Investigative ophthalmology & visual science"},{"key":"52156_CR39","doi-asserted-by":"crossref","unstructured":"Age-Related Eye Disease Study Research, G. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 107, 2224\u20132232 (2000).","DOI":"10.1016\/S0161-6420(00)00409-7"},{"key":"52156_CR40","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/bjo.2006.096123","volume":"90","author":"L Xu","year":"2006","unstructured":"Xu, L., Li, Y., Zheng, Y. & Jonas, J. B. Associated factors for age related maculopathy in the adult population in China: the Beijing eye study. Br J Ophthalmol 90, 1087\u20131090, https:\/\/doi.org\/10.1136\/bjo.2006.096123 (2006).","journal-title":"Br J Ophthalmol"},{"key":"52156_CR41","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ebiom.2018.01.024","volume":"28","author":"CC Wei","year":"2018","unstructured":"Wei, C. C. et al. Allergic Conjunctivitis-induced Retinal Inflammation Promotes Myopia Progression. EBioMedicine 28, 274\u2013286, https:\/\/doi.org\/10.1016\/j.ebiom.2018.01.024 (2018).","journal-title":"EBioMedicine"},{"key":"52156_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exer.2015.03.017","volume":"142","author":"X Zhu","year":"2016","unstructured":"Zhu, X. et al. Proinflammatory status in the aqueous humor of high myopic cataract eyes. Experimental eye research 142, 13\u201318, https:\/\/doi.org\/10.1016\/j.exer.2015.03.017 (2016).","journal-title":"Experimental eye research"},{"key":"52156_CR43","doi-asserted-by":"publisher","first-page":"e0180851","DOI":"10.1371\/journal.pone.0180851","volume":"12","author":"H Ohsugi","year":"2017","unstructured":"Ohsugi, H. et al. Axial length changes in highly myopic eyes and influence of myopic macular complications in Japanese adults. PLoS One 12, e0180851, https:\/\/doi.org\/10.1371\/journal.pone.0180851 (2017).","journal-title":"PLoS One"},{"key":"52156_CR44","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1001\/jamaophthalmol.2014.1011","volume":"132","author":"M He","year":"2014","unstructured":"He, M. et al. Two-year changes in refractive error and related biometric factors in an adult Chinese population. JAMA Ophthalmol 132, 978\u2013984, https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.1011 (2014).","journal-title":"JAMA Ophthalmol"},{"key":"52156_CR45","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1755-3768.2008.01472.x","volume":"88","author":"HC Fledelius","year":"2010","unstructured":"Fledelius, H. C. & Goldschmidt, E. Oculometry findings in high myopia at adult age: considerations based on oculometric follow-up data over 28 years in a cohort-based Danish high-myopia series. Acta Ophthalmol 88, 472\u2013478, https:\/\/doi.org\/10.1111\/j.1755-3768.2008.01472.x (2010).","journal-title":"Acta Ophthalmol"},{"key":"52156_CR46","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00417-012-2066-9","volume":"251","author":"N Saka","year":"2013","unstructured":"Saka, N. et al. Changes of axial length measured by IOL master during 2 years in eyes of adults with pathologic myopia. Graefe\u2019s archive for clinical and experimental ophthalmology\u2009=\u2009Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 251, 495\u2013499, https:\/\/doi.org\/10.1007\/s00417-012-2066-9 (2013).","journal-title":"Graefe\u2019s archive for clinical and experimental ophthalmology\u2009=\u2009Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52156-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52156-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52156-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:10:31Z","timestamp":1671289831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52156-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["52156"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-52156-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,31]]},"assertion":[{"value":"17 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jost B. Jonas: Patent holder with Biocompatibles UK Ltd. (Franham, Surrey, UK) (Title: Treatment of eye diseases using encapsulated cells encoding and secreting neuroprotective factor and\/or anti-angiogenic factor; Patent number: 20120263794), and patent application with University of Heidelberg (Heidelberg, Germany) (Title: Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia; Europ\u00e4ische Patentanmeldung 15 000 771.4). All other authors have no financial or non-financial disclosure and no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15708"}}